A refractory case of rapidly progressive glomerulonephritis due to microscopic polyangiitis

HIGHLIGHTS

• What: While current immunosuppressive therapies have significantly improved overall survival for patients with AAV, there remains a subset of patients who will prove refractory to these treatments, such as our patient described in the case above.
• Who: Report et al. from the System, Newark, USA have published the article: Review began 05/02/2024 Review ended 05/08/2024 Published 05/15/2024 © Copyright, in the Journal: (JOURNAL) of April/19,/2024
• Future: Studies are needed to help determine which patients would benefit from the early initiation of novel therapies such as avacopan . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.